SCHEMBL1498078

SCHEMBL1498078

CCCCC(CC(=O)O)(C(=O)O)S(=O)(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSPD1 P10809 1/20 0.36
BLM P54132 1/20 0.36
HSPE1 P61604 1/20 0.36
TDP1 Q9NUW8 3/20 0.35
FFAR1 O14842 2/20 0.35
CPT2 P23786 1/20 0.35
TSHR P16473 5/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C19 P33261 1/20 0.34
HIF1A Q16665 1/20 0.34
AKR1B1 P15121 1/20 0.34
GPR84 Q9NQS5 7/20 0.33
PPARG P37231 6/20 0.33
PPARD Q03181 6/20 0.33
PPARA Q07869 6/20 0.33
HDAC11 Q96DB2 5/20 0.33
ALDH1A1 P00352 2/20 0.33
TLR2 O60603 2/20 0.33
FABP4 P15090 2/20 0.33
PTPN1 P18031 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17666414 0.98 HSPD1 (0.35) HSPD1BLMHSPE1TDP1FFAR1
SCHEMBL3396398 0.95 TDP1 (0.38) HSPD1BLMHSPE1TDP1FFAR1
SCHEMBL573838 0.93 TDP1 (0.41) HSPD1BLMHSPE1TDP1FFAR1
SCHEMBL749698 0.93 TDP1 (0.41) HSPD1BLMHSPE1TDP1FFAR1
SCHEMBL9836853 0.93 TDP1 (0.41) HSPD1BLMHSPE1TDP1FFAR1
SCHEMBL2314036 0.93 TDP1 (0.41) HSPD1BLMHSPE1TDP1FFAR1
Tridecane SCHEMBL11754456 0.93 TDP1 (0.41) HSPD1BLMHSPE1TDP1FFAR1
SCHEMBL9645095 0.93 TDP1 (0.41) HSPD1BLMHSPE1TDP1FFAR1
SCHEMBL208623 0.93 TDP1 (0.41) HSPD1BLMHSPE1TDP1FFAR1
SCHEMBL1840384 0.93 TDP1 (0.41) HSPD1BLMHSPE1TDP1FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118879232-A Application of binder in preparation of secondary battery diaphragm surface coating layer, diaphragm and battery 深圳好电科技有限公司 2024-11-01 CN disclosed
US-9307757-B2 Monoalkyl sulfosuccinates in pesticide formulations and applications AKZO NOBEL CHEMICALS INTERNATIONAL B.V. (NL) 2016-04-12 US disclosed
EP-2480070-B1 Monoalkyl sulfosuccinates in pesticide formulations and applications as hydrotropes AKZO NOBEL CHEMICALS INT BV (NL) 2016-01-06 EP disclosed
WO-2014128210-A1 METHOD FOR PRODUCING POLYMER-COATED NANOPARTICLES BASF SE (DE) 2014-08-28 WO disclosed
EP-2480070-A2 MONOALKYL SULFOSUCCINATES IN PESTICIDE FORMULATIONS AND APPLICATIONS AS HYDROTROPES Akzo Nobel Chemicals International B.V. (NL) 2012-08-01 EP disclosed
US-20120172229-A1 MONOALKYL SULFOSUCCINATES IN PESTICIDE FORMULATIONS AND APPLICATIONS AKZO NOBEL CHEMICALS INTERNATIONAL B.V. (NL) 2012-07-05 US disclosed
WO-2011036152-A2 MONOALKYL SULFOSUCCINATES IN PESTICIDE FORMULATIONS AND APPLICATIONS AKZO NOBEL CHEMICALS INTERNATIONAL B.V. (NL) 2011-03-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120172229-A1 MONOALKYL SULFOSUCCINATES IN PESTICIDE FORMULATIONS AND APPLICATIONS AGPS, PFAS, GLUL HSPD1 3376/4885BLM 1807/4885HSPE1 2262/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.